These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 27256280

  • 1. Axillary radiotherapy in conservative surgery for early-stage breast cancer (stage I and II).
    García Novoa A, Acea Nebril B, Díaz I, Builes Ramírez S, Varela C, Cereijo C, Mosquera Oses J, López Calviño B, Seoane Pillado MT.
    Cir Esp; 2016; 94(6):331-8. PubMed ID: 27256280
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N, Demir D, Bati B, Yilmaz BD, Bati Y, Çaynak ZC, Sobutay E.
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [Abstract] [Full Text] [Related]

  • 6. Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome.
    Kuznetsova M, Graybill JC, Zusag TW, Hartsell WF, Griem KL.
    Radiology; 1995 Nov; 197(2):507-10. PubMed ID: 7480703
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
    Sanuki N, Takeda A, Amemiya A, Ofuchi T, Ono M, Ogata H, Yamagami R, Hatayama J, Eriguchi T, Kunieda E.
    Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Different radiation techniques to deliver therapeutic dose to the axilla in patients with sentinel lymph node-positive breast cancer: Doses, techniques challenges and clinical considerations.
    Wang S, Kirova YM, Shan SC, Cai G, Ou D, Cao L, Cai R, Chen JY.
    Cancer Radiother; 2018 Dec; 22(8):767-772. PubMed ID: 30523794
    [Abstract] [Full Text] [Related]

  • 10. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A, Musonda P, Mátrai Z, Polgár C, Rényi-Vámos F, Rubovszky G, Kovács E, Sinkovics I, Udvarhelyi N, Török K, Kásler M, Péley G.
    Orv Hetil; 2013 Dec 08; 154(49):1934-42. PubMed ID: 24292111
    [Abstract] [Full Text] [Related]

  • 11. Regional radiotherapy versus an axillary lymph node dissection after lumpectomy: a safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up.
    Spruit PH, Siesling S, Elferink MA, Vonk EJ, Hoekstra CJ.
    Radiat Oncol; 2007 Oct 30; 2():40. PubMed ID: 17971196
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
    Grills IS, Kestin LL, Goldstein N, Mitchell C, Martinez A, Ingold J, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2003 Jul 01; 56(3):658-70. PubMed ID: 12788171
    [Abstract] [Full Text] [Related]

  • 13. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C, Clough K, Asselain B, Vilcoq JR, Salmon RJ, Campana F, Fourquet A.
    J Clin Oncol; 2004 Jan 01; 22(1):97-101. PubMed ID: 14701770
    [Abstract] [Full Text] [Related]

  • 14. Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes.
    Hoebers FJ, Borger JH, Hart AA, Peterse JL, Th EJ, Lebesque JV.
    Cancer; 2000 Apr 01; 88(7):1633-42. PubMed ID: 10738222
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI.
    J Am Coll Surg; 1996 Dec 01; 183(6):575-82. PubMed ID: 8957459
    [Abstract] [Full Text] [Related]

  • 16. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC, Poortmans P, Strobbe LJA, Siesling S.
    Lancet Oncol; 2016 Aug 01; 17(8):1158-1170. PubMed ID: 27344114
    [Abstract] [Full Text] [Related]

  • 17. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
    Fodor J, Polgár C, Németh G.
    Orv Hetil; 2000 Jul 09; 141(28):1551-5. PubMed ID: 10957865
    [Abstract] [Full Text] [Related]

  • 18. Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?
    Martelli G, Miceli R, De Palo G, Coradini D, Salvadori B, Zucali R, Galante E, Marubini E.
    Cancer; 2003 Mar 01; 97(5):1156-63. PubMed ID: 12599220
    [Abstract] [Full Text] [Related]

  • 19. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.
    Vitucci C, Tirelli C, Graziano F, Santoro E.
    J Surg Oncol; 2000 Jun 01; 74(2):108-15. PubMed ID: 10914819
    [Abstract] [Full Text] [Related]

  • 20. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J, Polgár C, Péley G, Németh G.
    Orv Hetil; 2001 Sep 09; 142(36):1941-50. PubMed ID: 11680099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.